Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase 1 4Phase 3 2Phase EARLY_PHASE1 1

Status

Terminated 4Completed 3Withdrawn 2Unknown 2Recruiting 2Active not recruiting 2

Sponsor Class

INDUSTRY 3OTHER 1

Study Type

Interventional 4

Sponsor

Cancer Type

Genitourinary 4Thoracic 1Head & Neck 1Gastrointestinal 1Dermatologic 1

Conditions

Breast Neoplasms 412Carcinoma, Non-Small-Cell Lung 285Prostatic Neoplasms 208Neoplasms 202Neoplasm Metastasis 179Melanoma 164Multiple Myeloma 158Colorectal Neoplasms 157Leukemia, Myeloid, Acute 143Lung Neoplasms 132Leukemia 126Lymphoma 118Pancreatic Neoplasms 117Recurrence 111Ovarian Neoplasms 111Leukemia, Lymphocytic, Chronic, B-Cell 110Lymphoma, Non-Hodgkin 104Carcinoma, Renal Cell 104Brain Neoplasms 89Myelodysplastic Syndromes 88Precursor Cell Lymphoblastic Leukemia-Lymphoma 86Glioblastoma 84Lymphoma, Large B-Cell, Diffuse 80Lymphoma, Follicular 79Carcinoma, Hepatocellular 79Head and Neck Neoplasms 77Squamous Cell Carcinoma of Head and Neck 76Urinary Bladder Neoplasms 66Stomach Neoplasms 61Hodgkin Disease 59

Interventions

enzalutamide 2darolutamide 1abiraterone 1Nivolumab 1Docetaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 2 × Terminated × Prostatic Neoplasms, Castration-Resistant × Clear all
NCT05551117 2026-02-09

Tamarack

MacroGenics

Phase 2 Terminated
192 enrolled 20 charts
DermatologicGastrointestinalGenitourinaryHead & NeckThoracic

Squamous Cell Carcinoma of Head and Neck, Anus Neoplasms, Carcinoma, Non-Small-Cell Lung, Melanoma, Carcinoma, Small Cell, Small Cell Lung Carcinoma, Prostatic Neoplasms, Castration-Resistant

NCT05169684 2025-06-10

A Study of BMS-986218 or BMS-986218 Plus Nivolumab in Combination With Docetaxel in Participants With Metastatic Castration-resistant Prostate Cancer

Bristol-Myers Squibb

Phase 2 Terminated
10 enrolled 15 charts
Genitourinary

Neoplasm Metastasis, Prostatic Neoplasms, Castration-Resistant

NCT04918810 2024-11-22

GUIDE

Australian and New Zealand Urogenital and Prostate Cancer Trials Group

Phase 2 Terminated
6 enrolled
Genitourinary

Prostatic Neoplasms, Castration-Resistant

NCT04157088 2023-08-04

DaroAcT

Bayer

Phase 2 Terminated
30 enrolled 25 charts
Genitourinary

Prostatic Neoplasms, Castration-Resistant

Data powered by HemOnc (CC BY 4.0) Colophon âš¡